Teva to cut 14,000 jobs
By 
Andy Extance2017-12-22T11:29:00
Saddled with debt in an increasingly competitive generic drug industry, the Israel-headquartered giant begins a difficult transformation
Drug manufacturer Teva will lay off more than a quarter of its workforce over the next two years, eliminating 14,000 positions globally. This drastic move prompted a strike in Israel, its home country, shutting banks, Tel Aviv airport, government ministries and a stock exchange for half a day on 17 December.